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Abstract 
Recent studies have shown that smoking and alcoholism may be associated with 
altered DNA methylation and that alcohol consumption might induce changes in DNA 
methylation by altering homocysteine metabolism. 
In this monocenter study, we included 363 consecutive patients referred to hospital for 
alcohol detoxification treatment. Blood samples were obtained on treatment days 1, 3 
and 7 for measurement of global DNA methylation in leucocytes by liquid 
chromatography tandem mass spectrometry. Genomic DNA was used for genotyping 
the following seven genetic variants of homocysteine metabolism: cystathionine beta-
synthase (CBS) c.844_855ins68, dihydrofolate-reductase (DHFR) c.594+59del19bp, 
methylenetetrahydrofolate-reductase (MTHFR) c.677C>T and c.1298A>C, 
methyltetrahydrofolate-transferase (MTR) c.2756A>G, reduced folate carrier 1 (RFC1) 
c.80G>A, and transcobalamin 2 c.776C>G. 
Multivariate linear regression showed a positive correlation of global DNA methylation 
with alcohol consumption and smoking on day 1 of hospitalization. DNA methylation 
was not correlated with homocysteine or vitamin plasma levels nor with the tested 
genetic variants of homocysteine metabolism. 
This suggests a direct effect of alcohol consumption and smoking on DNA methylation, 
which is not mediated by effects of alcohol on homocysteine metabolism. 
 
 
 
Keywords: alcohol; alcohol abuse; alcohol dependence; smoking; DNA methylation; 
homocysteine; folate; vitamin B1, vitamin B2; vitamin B6, vitamin B12; single nucleotide 
polymorphism 
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Introduction 
Tobacco and alcohol are the most commonly used noxious compounds worldwide. 
Cigarette smoking and alcoholism significantly increase the risk for a variety of medical 
and psychiatric conditions and different forms of cancer (Thun et al., 1997; Zaridze et 
al., 2009). Because of the high prevalence of alcoholism and tobacco abuse and their 
negative health consequences, it is important to understand the mechanisms involved 
in alcohol and tobacco dependence and toxicity. A growing number of studies have 
shown that alcoholism and chronic alcohol intake in non-addicted subjects may be 
associated with altered DNA methylation (Bonsch, Lenz, Reulbach, Kornhuber, & 
Bleich, 2004; Harlaar & Hutchison, 2013; Starkman, Sakharkar, & Pandey, 2012). 
Some studies have demonstrated an additive effect of alcohol consumption and 
smoking on changes in DNA methylation (Thapar, Covault, Hesselbrock, & Bonkovsky, 
2012). Alcohol might induce changes in DNA methylation by altering homocysteine 
metabolism (Bleich et al., 2000; Bleich & Hillemacher, 2009; Bonsch et al., 2004; 
Varela-Rey, Woodhoo, Martinez-Chantar, Mato, & Lu, 2013).  
DNA methylation depends on S-adenosylmethionine (SAM) as a methyl group donor. 
The demethylated residue of SAM is S-adenosylhomocysteine (SAH), which is 
reversibly hydrolyzed to homocysteine. In a vitamin B6-dependent pathway, 
homocysteine can be transsulfurated to cystathionine and cysteine (Figure 1). 
Alternatively, homocysteine can be remethylated, depending on the essential co-factors 
folate, vitamin B2 and vitamin B12. As vitamin deficiency commonly occurs in alcohol-
dependent patients, alcohol-induced changes in DNA methylation and homocysteine 
might be explained by vitamin deficiencies (Cravo & Camilo, 2000; Heese et al., 2012). 
Not only the vitamin status, but also genetic variants may modify folate, vitamin B12 
and homocysteine metabolism (Stover, 2011). Alcohol-induced changes of DNA 
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methylation are possibly influenced by these genetic variants which are common in the 
general population. 
In a cohort of 363 patients with alcohol dependency, we analyzed changes of DNA 
methylation and attempted to identify parameters related to homocysteine metabolism 
which may mediate or modify the association of alcohol and DNA methylation, i.e. 
plasma levels of homocysteine and vitamins involved in homocysteine metabolism as 
well as genetic variants of homocysteine metabolism.  
 
Materials and Methods 
Patients 
The present study is part of the German Investigation on Neurobiology in Alcoholism 
(GINA)(Heese et al., 2012). Consecutive patients were recruited from the Department 
of Addiction and Psychotherapy of the LVR-Clinic in Bonn, Germany (Heese et al., 
2012). All participants were diagnosed with alcohol dependency according to ICD-10 
and were included in the study on admission for alcohol detoxification. Patients were 
mainly detoxified with clomethiazole following a symptom-triggered regime using the 
Banger-Score (Banger, Philipp, Herth, Hebenstreit, & Aldenhoff, 1992). If, for clinical 
reasons, clomethiazole could not be used, benzodiazepines were administered. 
Patients diagnosed with dependence from other substances were excluded. Daily 
alcohol consumption was calculated per day according to patients’ self-reported alcohol 
consumption within the last week before admission to the hospital. Fasting blood 
samples were obtained on days 1 (admission), 3 and 7 of the detoxification treatment. 
Blood samples were centrifuged and consecutive serum and lithium heparin plasma 
samples were stored at −80°C directly after collection. Homocysteine and global DNA 
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methylation were assessed at all three time points, while vitamin serum levels were 
obtained at admission.  
This study was approved by the local ethics committee. All patients gave their informed 
written consent.  
 
Biochemical measurements  
Serum alcohol concentrations were measured by an enzymatic test (alcohol 
dehydrogenase method) with a Dimension Vista™ system (Siemens Healthcare 
Diagnostics, Eschborn, Germany). 
Serum alanine aminotransferase (ALT) activity, aspartate aminotransferase (AST) 
activity and gamma glutamyl transferase (GGT) activity were measured by means of an 
enzymatic test (ALTI method, AST method, GGT method) with a Dimension Vista™ 
system (Siemens Healthcare Diagnostics). Reference intervals for ALT ranged up to 45 
U/l for men and 34 U/l for women, reference intervals for AST ranged from up to 35 U/l 
for men and 31 U/l for women, and reference intervals for GGT ranged up to 55 U/l for 
men and 38 U/l for women. 
Serum carbohydrate-deficient transferrin (CDT) and serum transferrin were measured 
by means of particle-enhanced immunonephelometry using a BN Prospec™ System 
(Siemens Healthcare Diagnostics). Reference intervals given by Siemens Healthcare 
Diagnostics ranged from 28.1 - 76.0 mg/l (1st to 99th percentile), CDT values with 
reference to the results obtained with the N antiserum to human transferrin ranged from 
1.19 – 2.47 %.  
Blood cell count was measured using a Sysmex XE 5000™ System (Sysmex 
Corporation, Kobe, Japan). Erythrocyte count was performed in a separate measuring 
channel according to the principle of impedance measurement with hydrodynamic 
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focusing. Measurement of hematocrit was based on the precise erythrocyte count. The 
impulse of each cell is proportional to its cell volume. Cumulative impulse height 
summation adds the analyzed impulses and corresponding cell volumes in a defined 
sample volume to reach the hematocrit value. Mean corpuscular volume (MCV, [fl]) was 
calculated from hematocrit [%] x 10 divided by erythrocyte count [Mio/µl].  
Homocysteine was determined by fully automated particle-enhanced 
immunonephelometry with a BN II System (Siemens Healthcare Diagnostics, Eschborn, 
Germany) by enzymatic conversion to S-adenosyl-homocysteine (SAH). The reference 
range for homocysteine is 5.8 - 11.9 µmol/L. The intra-assay coefficient of variation of 
the homocysteine assay was 3.4% (mean: 11 µmol/L, n=20), the inter-assay coefficient 
was 5.6% (mean: 11 µmol/L l, n=20). 
Plasma concentrations of vitamin B1, vitamin B2 and vitamin B6 were analyzed using 
commercially available HPLC assays (Chromsystems Instruments & Chemicals GmbH, 
Munich, Germany) on an HPLC system with a fluorescence detector (Agilent.Series 
1200, Agilent, Waldbronn, Germany). Reference intervals given by Chromsystems were 
66.5 – 200 nmol/L for vitamin B1, 174 – 471 nmol/L for vitamin B2 and 35.2 – 110.5 
nmol/L for vitamin B6. The intra-assay coefficient of variation of the vitamin B6 assay 
was 5.3% (mean: 10.4 µg/l; n=20), while the inter-assay coefficient of variation was 
6.5% (mean: 10.5 µg/l; n=20).  
Plasma concentrations of vitamin B12 and folate were measured by means of a 
competitive chemiluminescence immunoassay with an Access™ Immunoassay System 
(Beckman Coulter, Krefeld, Germany) according to the manufacturer’s instructions. The 
reference range of vitamin B12 is 130-680 pmol/L and the reference range of folate is 
6.8-30 nmol/L. The intra-assay coefficient of variation of the vitamin B12 assay was 
3.8% (mean: 487 pmol/L; n=20), the inter-assay coefficient was 4.2% (mean: 492 
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pmol/L; n=20). The intra-assay coefficient of variation of the folate assay was 3.1% 
(mean: 14.1 nmol/L; n=20), while the inter-assay coefficient of variation was 3.6% 
(mean: 14.3 nmol/L; n=20).  
 
Genotyping 
Genomic DNA prepared from leukocytes was used for genotyping by PCR amplification 
and subsequent restriction analysis of seven genetic variants of homocysteine 
metabolism. CBS c.844_855ins68 (change of transcript levels, Genbank Number 
S78267.1, no restriction digest necessary)(Tsai, Bignell, Schwichtenberg, & Hanson, 
1996), DHFR c.594+59del19bp (change of transcript levels, no restriction digest 
necessary, rs70991108)(Johnson et al., 2004), MTHFR c.677C>T (A222V, restriction 
enzyme Hinf, rs1801133)(Frosst et al., 1995) and c.1298A>C (E429A, restriction 
enzyme MboII, rs1801131)(van der Put et al., 1998), MTR c.2756A>G (D919G, 
restriction enzyme HaeIII, rs1805087)(Leclerc et al., 1996), reduced folate carrier 1 
(RFC1) c.80G>A (R27H, restriction enzyme Cfo1, rs1051266)(Chango et al., 2000; 
Linnebank et al., 2006; Moskau et al., 2005), and transcobalamin 2 c.776C>G (P259R, 
restriction enzyme ScrF1, rs 1801198)(Afman, Lievers, van der Put, Trijbels, & Blom, 
2002). 
 
Determination of global DNA methylation 
Global DNA methylation was measured by ultra-high performance liquid 
chromatography (UHPLC) tandem mass spectrometry with a method adapted from the 
work done by Kok and coworkers (Kok et al., 2007). In short, 2 µg of DNA were 
hydrolyzed using formic acid. Cytosine (cyt) and 5-methylcytosine (mcyt) were 
separated using an Ultimate 3000 LC system (Dionex, Sunnyval, CA, USA) and an 
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Acquity BEH Amide column (1.7 µm, 2.1x100 mm, Water Corporation, Milford, MA, 
USA). The mobile phase was consisting of (A) MeCN/H2O 1:1 and (B) MeCN/H2O 95:5, 
both buffered with 10 mM NH4HCO2 and 0.125% HCOOH (v/v). The compounds were 
eluted with a linear gradient from 95 to 85% in 4 min at 0.5 mL•min–1 flow rate. The 
column was then washed with 50% of solvent B during 2 min and reconditioned during 
2 min until the next injection. The UHPLC system was coupled to a 3200 QTRAP 
electospray ionization tandem mass spectrometer (AB Sciex, Foster City, CA, USA) 
operating in the multiple reaction monitoring mode and quantified using labeled internal 
standards. MS/MS transitions with 150 ms dwell time from m/z 112.0 to 95.0, 117.0 to 
99.0, 126.0 to 109.0, and 130.1 to 113.0 were chosen for the detection of cyt, mcyt, 2,4-
[13C2,15N3]-cyt, and 5-methyl-d3-cytosine-6-d1, respectively. The level of DNA 
methylation is expressed as the mcyt/total-cytosine ratio (mcyt/tcyt). 
The intra- and inter-assay coefficient of variation (CV) for the mcyt/tcyt was 1.7% (n = 9) 
and 3.5% (n = 9) for calf thymus DNA (mean mCyt/tCyt ratio 6.5%), respectively. 
 
Statistics 
Deviations from Hardy-Weinberg equilibrium were separately analyzed using the χ2 
goodness of fit test, comparing observed and expected numbers for each genetic 
variant (α = 0.05). We used multivariate linear regression with the global leukocyte DNA 
methylation on the day of admission as dependent variable and age, gender, body 
mass index, cigarette consumption per day, daily alcohol consumption, vitamin plasma 
levels and the seven included single nucleotide polymorphisms as independent 
variables. α = 0.05 was defined as significance level.  
 
Results 
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We included 363 serial patients (250 men, 113 women). Demographic and laboratory 
data determined at admission are shown in Table 1. 
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From the day of admission (day 1) 344 samples were available. A significant number of 
patients left the hospital before alcohol detoxification was completed or refused 
participation on some days of the study. Therefore, on day 3, n=59 samples and on day 
7, n=75 samples were available. Self-reported alcohol consumption before admission 
was 218 g/d (± 119), Figure 2. 23% (n=83) of the study population were non-smokers. 
The rest of the study population reported tobacco consumption with a mean 
consumption of 18.4 (± 13.6 1SD) cigarettes per day.  
 
Multivariate linear regression showed that on the day of admission (day 1), global 
leucocyte DNA methylation correlated with alcohol consumption per day and cigarette 
consumption per day. There was no correlation of global leukocyte DNA methylation 
with age, gender, vitamin plasma levels or the seven single nucleotide polymorphisms 
(table 3).  
Samples drawn on day 3 of the study showed a positive correlation of global DNA 
methylation with cigarette consumption, but not with alcohol consumption. On day 7, 
neither alcohol consumption nor cigarette consumption were significantly associated 
with global DNA methylation in leucocytes. When analysis was confined to patients who 
remained in hospital until days 3 or 7, no significant change in DNA methylation was 
detectable over time. 
When the small group of non-smokers was analyzed separately, there was no 
significant association between the global DNA methylation and daily alcohol 
consumption (Beta 0.162; p=0.27). When only smokers were included analysis showed 
an association between global DNA methylation and daily alcohol consumption on the 
day of admission (Beta 0.154; p=0.04).  
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As homocysteine plasma levels strongly depend on serum levels of folate, vitamin B1, 
B6 and B12 (Heese et al., 2012; Mudd, Levy, & Kraus, 2001), homocysteine was not 
included in multivariate analyses. Bivariate Pearson analyses  revealed no significant 
correlation between homocysteine plasma levels and DNA methylation on day 1 
(p=0.626), day 3 (p=0.871) or day 7 (p=0.624). 
 
 
Discussion 
This study shows that global DNA methylation in leukocytes correlates with the amount 
of daily alcohol consumption and cigarette smoking in alcohol dependent patients 
suggesting that both alcohol and tobacco provide an increase in global DNA 
methylation. We found no positive correlation with alcohol consumption on day 3, and 
no correlation with alcohol consumption or smoking on day 7. However, a large number 
of patients left the hospital before detoxification was completed on day 7. When 
analysis was confined to patients who remained in hospital until days 3 or 7, no 
significant change in DNA methylation was detectable over time. Thus, the lack of a 
correlation between alcohol consumption and DNA methylation on days 3 and 7 might 
be explained by drop-outs rather than by a change of methylation during detoxification. 
When smokers and non-smokers were analyzed separately, the association of global 
DNA methylation and daily alcohol consumption could only be found in smokers. The 
data of this study does not allow to decide whether this finding is due to separate 
analysis of a small subgroup (non-smokers), or if any impact of alcohol on DNA 
methylation only becomes effective in smokers. 
No association of DNA methylation with vitamin or homocysteine plasma levels was 
found. Therefore, the increase in global DNA methylation cannot be explained by 
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vitamin deficiency or metabolic consequences of chronic alcohol consumption, such as 
liver dysfunction. This is surprising as dietary and metabolic factors are known to 
influence DNA methylation (Davis & Uthus, 2004; Ulrey, Liu, Andrews, & Tollefsbol, 
2005), and malnutrition and liver dysfunction are common in alcohol-dependent 
patients. Possibly, DNA hypermethylation in alcohol-dependent patients is a direct, 
dose-related consequence of alcohol consumption rather than a dietary and metabolic 
consequence.  
Our findings also show that genetic variants of key enzymes of methylation metabolism 
are not associated with DNA methylation in alcohol dependent patients, suggesting that 
the tested variants do not contribute to hypermethylation in alcohol dependent patients. 
According to our findings, changes in global DNA methylation in alcohol dependent 
patients cannot be explained by changes in homocysteine metabolism. Direct inhibition 
of DNA methyltransferases by alcohol has previously been described as a potential 
mechanism of DNA hypermethylation in alcohol dependence, which could also be the 
case in our patient sample (Bonsch et al., 2006; Varela-Rey et al., 2013).  
Cigarette smoking and alcoholism significantly contribute to a great variety of medical 
conditions, especially to different forms of cancer (Varela-Rey et al., 2013; Zaridze et 
al., 2009). Several factors potentially promote alcohol-induced cancer development, 
such as toxic effects of ethanol metabolites and oxidative stress. This study provides 
additional evidence that aberrant patterns of DNA methylation could also contribute to 
alcohol-tobacco induced disease development.  
Other authors have described different results. Thapar et al. found decreased DNA 
methylation when alcohol dependence was combined with smoking (Thapar et al., 
2012). The difference between this these findings and the present study may be 
explained by a smaller sample size and a lower amount of alcohol consumption in the 
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alcohol dependent subjects included in the study of Thapar et al. (n=25 alcoholics). It 
has also been reported that occasional alcohol consumption in healthy subjects leads 
to DNA hypomethylation (Zhu et al., 2012). However, studies including healthy subjects 
with occasional alcohol consumption and studies including subjects with alcohol 
dependence and heavy consumption may not be comparable. The same argument 
holds true for studies with negative results of alcohol consumption and DNA 
methylation in healthy subjects (Ono et al., 2012; Zhang et al., 2011).  
The strengths of the present study are its sample size, the characteristics of the study 
population including only alcohol dependent patients with heavy alcohol consumption, 
and the inclusion of important dietary and genetic factors, such as homocysteine and 
vitamin plasma levels and the polymorphisms of seven important genetic variations of 
methylation metabolism. One important limitation is that a significant number of study 
participants dropped out of the study after day 1, considerably limiting the number of 
available samples from day 3 and day 7 after alcohol cessation. Unfortunately, this 
study does not contain data which relate the differences in DNA methylation with a 
functional effect. Neither can it provide data on the molecular mechanisms underlying 
the effects of alcohol and smoking on global DNA methylation. Also, DNA methylation 
patterns are frequently tissue- and cell-specific, reflecting tissue-specific regulation of 
DNA methylation (Khavari, Sen, & Rinn, 2010). Therefore, methylation patterns should 
ideally be examined in the tissue that is directly related to the outcome of interest. Thus, 
further tissues of interest, such as brain and liver, should be tested in animal studies. 
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Figure 1. Homocysteine metabolism 
The sulfur-containing amino acid methionine is activated to S-adenosylmethionine (SAM), 
which is a ubiquitous methyl group donor. The degradation product of SAM is S-
adenosylhomocysteine (SAH), which is hydrolyzed to homocysteine. Homocysteine can be 
remethylated to methionine and SAM via methionine synthase (MTR), which depends on 
derivatives of folate and vitamin B12 as cofactors. Lack of these vitamins is a common cause of 
hyperhomocysteinemia (Mudd et al., 2001). The folate derivative is synthesized by 
methylenetetrahydrofolate reductase (MTHFR) and dihydrofolate reductase (DHFR), and the 
derivative of vitamin B12 is transported by transcobalamin 2 (Tc2). Alternatively, homocysteine 
can be transsulfurated by vitamin B6 dependent cystathionine β-synthase (CBS) and 
cystathionine gamma-lyase (CGL) to cysteine as a component of glutathione. Due to the 
existence of several functional variants in the genes involved in homocysteine metabolism, and 
to differences in dietary vitamin and amino acid uptake, disorders of homocysteine metabolism 
exhibit marked inter-individual differences. 
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Figure 2. Histogram of the daily alcohol consumption within the study population  
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 minimum maximum mean 1 standard 
deviation 
Age (yr) 35 87 61.8 9.4 
Height (cm) 150 197 173.8 8.7 
Weight (kg) 41 137 75.9 16.0 
Body mass index 15.2 47.1 25.1 4.6 
Daily alcohol (g) 30 840 218 119 
CDT (%) 1.50 16.8 4.6 3.0 
Pack years 0 76 22.4 17.3 
Daily cigarettes 0 60 18.4 13.7 
GGT (U/L) 3 5787 296 578 
ALT (U/L) 9 311 66.6 59.3 
AST (U/L) 4.9 566 83.5 87.5 
MCV (fl) 34 219 95 9.7 
Homocysteine (µmol/L) 5.5 131 20.8 15.2 
Folate (ng/ml) 1.6 247.9 10.2 14.2 
Vitamin B1 (nmol/L) 16.8 670.0 168.4 52.8 
Vitamin B2 (nmol/L) 7.85 2551 308.6 136.1 
Vitamin B6 (µmol/L) 3.74 522.60 30.9 38.1 
Vitamin B12 (pg/L) 4.1 1500 685 295 
DNA methylation (%) 1.50 5.50 3.72 0.66 
 
Table 1. Demographic data and descriptive statistics of the study population. 
 23 
The distribution of all genotypes was within the Hardy-Weinberg-equilibrium. Genotype 
analysis was not possible for 20 patients, either due to the quality of the sample or 
because patients did not agree with the genetic component of the study.  
  
 
MTHFR c.1298A>C AA AC CC 
 0.48 0.44 0.08 
MTHFR c.677C>T CC CT TT 
 0.46 0.44 0.10 
Tc2 c.776C>G CC CG GG 
 0.26 0.50 0.24 
MTR 2756A>G AA AG GG 
 0.69 0.26 0.24 
RFC1 c.80G>A GG AG AA 
 0.32 0.45 0.23 
CBS844ins68bp del/del del/ins ins/ins 
 0.83 0.16 0.02 
DHFR 
c.594+59del19bp 
del/del del/ins ins/ins 
 0.30 0.47 0.23 
 
Table 2. Results of genotyping for seven genetic variants of methylation metabolism. 
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 Beta p 
Age -0.044 0.48 
Gender 0.21 0.73 
Cigarettes per day 0.159 0.01 
Daily alcohol consumption g/d 0.188 <0.001 
Vitamin B1 nmol/L 0.102 0.11 
Vitamin B2 nmol/L 0.069 0.35 
Vitamin B6 µg/L 0.057 0.356 
Vitamin B12 pg/L -0.051 0.42 
Folate ng/ml -0.072 0.33 
MTHFR c.1298A>C -0.013 0.85 
MTHFR c.677C>T 0.006 0.92 
Tc2 c.776C>G 0.104 0.09 
MTR 2756A>G 0.019 0.76 
RFC1 c.80G>A 0.063 0.31 
CBS844ins68bp 0.022 0.72 
DHFR c.594+59del19bp 0.010 0.87 
 
Table 3. Multivariate linear regression of  global leukocyte DNA methylation on the day 
of admission with age, gender, cigarette consumption per day, vitamins and seven 
single nucleotide polymorphisms as co-factors. α = 0.05 was defined as significance 
level. n= 344 patients were included on the day of admission to the hospital. 
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 Beta p 
Cigarettes per day 0.374 0.04 
Daily alcohol consumption g/d 0.109 0.41 
 
 
Table 4. Multivariate linear regression of the global leukocyte DNA methylation on the 
third day after admission with age, gender, cigarette consumption per day, blood 
alcohol on admission, vitamins and seven single nucleotide polymorphisms as co-
factors. α = 0.05 was defined as significance level. Results, which were not significant 
on day 1, are not shown. n = 59 patients were included. 
 
 
 Beta p 
Cigarettes per day 0.084 0.57 
Daily alcohol consumption g/d -0.021 0.86 
 
 
Table 5. Multivariate linear regression of the global leukocyte DNA methylation on day 7 
after admission with age, gender, cigarette consumption per day, blood alcohol on 
admission, vitamins and the seven included single nucleotide polymorphisms as co-
factors; α = 0.05 was defined as significance level. Results, which were not significant 
on day 1, are not shown. n= 75 patients were included. 
 
 
